Clay Siegall Leads The Forefront Of Cancer Research

Clay Siegall, co-founder and CEO, of Seattle Genetics is known for his extensive research in cancer and antibody’s that fight against hereditary and debilitating diseases. He also serves as the President and on the Board of Directors. His leadership abilities helped him excel when cancer was a new disease to the medical industry. He worked as a leadership professional for big name pharmaceutical GlaxoSmith-Kline for over 15+ years. His focus is fighting the symptoms of the effects of chemotherapy by creating a less invasive treatment. It is important to help improve the lives of cancer patients everywhere by fighting hard against cancer.

Seattle Genetics is committed to cancer research under Clay Siegall. his goal is to change the era that cancer is dominated by chemotherapy. There was a need to eliminate killing cancer cells and normal cells and Seattle Genetics was ready to respond with comprehensive treatment. He was one of the first of his kind in the cancer research industry to stand up for a need to eliminate chemotherapy to increases the chances of remission. He fights for cancer patients by making a stand behind the medicine that is used in a combination with other treatments.

You can learn more about Clay Siegall’s professional career by visiting his LinkedIn or the Seattle Genetics website. He says, his overall goal is to keeping improving the life of his patients with integrative cancer treatment and securing generous donations through other big name companies fighting the same cause. You’re invited to learn more about Seattle Genetics today and dedicate time and money to save the life of cancer patient today.


About the author


View all posts